Hetero | Zee News

Advertisement

Hetero News

06 Sep 2021

India's fight against COVID-19 gets stronger, Tocilizumab drug gets DCGI's nod

India's fight against COVID-19 got stronger on Monday. Hetero's Tocilizumab biosimilar got DCGI's nod for treatment of hospitalised patients The drug is the biosimilar version of Roche's Actemra/RoActemra and will be available from September-end.

coronavirus medicine

21 Jun 2020

COVID-19: Hetero gets DCGI nod to launch anti-viral drug remdesivir

The company has received the manufacturing and marketing approval for Remdesivir from the Drug Controller General of India (DCGI) for the treatment of COVID-19, it said in a statement.

23 Mar 2015

Dr Reddy's to launch Hepatitis C drug in India

Dr Reddy's Laboratories today entered into an agreement with Hetero to distribute and market generic version of US-firm Gilead Sciences' Hepatitis C drug under the brand 'Resof' in India.

Loading...

NEWS ON ONE CLICK